About International Biotechnology Trust (LON:IBT)
International Biotechnology Trust plc is an investment trust company. The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies, which may be quoted or unquoted and whose shares are considered to have growth prospects, with experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. It may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Investments may also be made in related sectors, such as medical devices and healthcare services. Its portfolio is split between large, mid and small-capitalization companies, primarily quoted on stock exchanges in North America. Its investment manager is SV Life Sciences Managers LLP.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity8.30%
Return on Assets7.65%
International Biotechnology Trust (LON:IBT) Frequently Asked Questions
What is International Biotechnology Trust's stock symbol?
International Biotechnology Trust trades on the London Stock Exchange (LON) under the ticker symbol "IBT."
How often does International Biotechnology Trust pay dividends? What is the dividend yield for International Biotechnology Trust?
International Biotechnology Trust declared a dividend on Thursday, November 2nd. Investors of record on Thursday, January 4th will be paid a dividend of GBX 13.50 per share on Wednesday, January 31st. This represents a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, January 4th. This is a boost from International Biotechnology Trust's previous dividend of $11.50. The official announcement can be accessed at this link. View International Biotechnology Trust's Dividend History.
Has International Biotechnology Trust been receiving favorable news coverage?
Media coverage about IBT stock has trended somewhat positive recently, Accern Sentiment reports. The research group ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. International Biotechnology Trust earned a coverage optimism score of 0.08 on Accern's scale. They also gave news headlines about the company an impact score of 44.88 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of International Biotechnology Trust?
Shares of IBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is International Biotechnology Trust's stock price today?
One share of IBT stock can currently be purchased for approximately GBX 619.96.
How big of a company is International Biotechnology Trust?
International Biotechnology Trust has a market capitalization of £220.09 million.
MarketBeat Community Rating for International Biotechnology Trust (IBT)MarketBeat's community ratings are surveys of what our community members think about International Biotechnology Trust and other stocks. Vote "Outperform" if you believe IBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBT will underperform the S&P 500 over the long term. You may vote once every thirty days.